Effect of thyroid hormone replacement on lipoprotein(a), lipids, and apolipoproteins in subjects with hypothyroidism

Mayo Clinic Proceedings

Volumn 73, Issue 9, 1998, Pages 837-841

  Martînez Triguero, Maria L ^a   Hernândez Mijares, Antonio ^a   Nguyen, Tu T ^a   Munoz, Maria L ^a   Pena, Hector ^a   Morillas, Carlos ^a   Lorente, David ^a   Lluch, Irene ^a   Molina, Ernesto ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; CHOLESTEROL; DEXTRAN SULFATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEVOTHYROXINE; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM CHLORIDE; THYROID HORMONE; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM;

EID: 0031686061     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/73.9.837     Document Type: Article

References (40)

1. Vanhaelst L, Neve P, Chailly P, Bastenie PA. Coronary-artery disease in hypothyroidism: observations in clinical myxoedema. Lancet 1967;2:800-802
2. Steinberg AD. Myxedema and coronary artery disease-a comparative autopsy study. Ann Intern Med 1968;68:338-344
3. Aviram M, Luboshitzky R, Brook JG. Lipid and lipoprotein pattern in thyroid dysfunction and the effect of therapy. Clin Biochem 1982:15:62-66
4. Agdeppa D, Macaron C, Mallik T, Schnuda ND. Plasma high density lipoprotein cholesterol in thyroid disease. J Clin Endochnol Metab 1979;49:726-729
5. Lithell H, Boberg J, Hellsing K, Ljunghall S, Lundqvist G, Vessby B, et al. Sérum lipoprotein and apolipoprotein concentrations and tissue lipoprotein-lipase activity in overt and subclinical hypothyroidism: thé effect of substitution therapy. Eur J Clin Invest 1981:11:3-10
6. Berg K. A new serum type system in man-the Lp system. Acta Pathol Microbiol Scand 1963:59:369-382
7. Scanu AM. Lipoprotein(a). Baillieres Clin Endocrinol Metab 1990:4:939-946
8. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ 1990:301:1248-1251
9. Schaefer EJ, Lamon-Fava S, Jenner JL, McNamara JR, Ordovas JM, Davis CE, et al. Lipoprotein(a) levels and risk of coronary heart disease in men: the Lipid Research Clinics Coronary Primary Prevention Trial. JAMA 1994:271:999-1003
10. Durrington PN. Lipoprotein(a). Baillieres Clin Endocrinol Metab 1995:9:773-795
11. Zioncheck TF, Powell LM, Rice GC, Eaton DL, Lawn RM. Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages. J Clin Invest 1991:87:767-771
12. Seed M, O'Connor B, Perombelon N, O'Donnell M, Reaveley D, Knight BL. The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover. Atherosclerosis 1993:101:61-68
13. Sacks FM, Gerhard M, Walsh BW. Sex hormones, lipoproteins, and vascular reactivity. Curr Opin Lipidol 1995:6:161-166
14. Haines CJ, Chung TKH, Masarei JRL, Tomlinson B, Lau JTF. An examination of the effect of combined cyclical hormone replacement therapy on lipoprotein(a) and other lipoproteins. Atherosclerosis 1996:119:215-222
15. Eden S, Wiklund O, Oscarsson J, Rosen T, Bengtsson BA. Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb 1993:13:296-301
16. Klausen 1C, Nielsen FE, Hegedus L, Gerdes LU, Charles P, Faergeman 0. Treatment of hypothyroidism reduces low-density lipoproteins but not lipoprotein(a). Metabolism 1992;41:911-914
17. Pazos F, Alvarez JJ, Rubies-Prat J, Varela C, Lasunciôn MA. Longterm thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins. J Clin Endocrinol Metab 1995:80:562-566
18. Spandrio S, Sleiman I, Scalvini T, Salvi A, Di Stefano 0, Pagliaini R, et al. Lipoprotein(a) in thyroid dysfunction before and after treatment. Horm Metab Res 1993:25:586-589
19. L9. de Bruin TWA, van Barlingen H, van Linde-Sibenius Trip M, van Vuurst de Vries A-RR, Akveld MJ, Erkelens DW. Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects. J Clin Endocrinol Metab 1993;76:121-126
20. Engler H, Riesen WF. Effect of thyroid function on concentrations of lipoprotein(a). Clin Chem 1993:39:2466-2469
21. Boland J, Carey G, Krodel E, Kwiatkowski M. The Ciba Corning ACS:180 benchtop immunoassay analyzer. Clin Chem 1990:36:1598-1601
22. Bachorik PS. Measurement of total cholesterol, HDL-cholesterol, and LDL-cholesterol. Clin Lab Med 1989 Mar;9:61-72
23. Finley PR, Schifman RB, Williams RJ, Lichti DA. Cholesterol in high density lipoprotein: use of Mg2/dextran sulfate in its enzymic measurement. Clin Chem 1978:24:931-933
24. Friedewald WT, Levy Rl, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972:18:499-502
25. Jenner JL, Ordovâs JM, Lamon-Fava S, Schaefer MM, Wilson PW, Castelli WP, et al. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels: the Framingham Offspring Study. Circulation 1993:87:1135-1141
26. Maciejko JJ, Levinson SS, Markyvech L, Smith MP, Blevins RD. New assay of apolipoproteins A-l and B by rate nephelometry evaluated. Clin Chem 1987:33:2065-2069
27. Labeur C, Michiels G, Bury J, Usher DC, Rosseneu M. Lipoprotein(a) quantified by an enzyme-linked immunosorbent assay with monoclonal antibodies. Clin Chem 1989:35:1380-1384
28. Castelli WP, Abbott RD, McNamara PM. Summary estimates of cholesterol used to predict coronary heart disease. Circulation 1983:67:730-734
29. Bastenie PA, Vanhaelst L, Neve P. Coronary-artery disease in hypothyroidism. Lancet 1967:2:1221-1222
30. Staels B, Van Toi A, Chan L, Will H, Verhoeven G, Auwerx J. Alter ations in thyroid status modulate apolipoprotein, hepatic triglycéride lipase, and low density lipoprotein receptor in rats. Endocrinology 1990:127:1144-1152
31. Gross G, Sykes M, Arellano R, Fong B, Angel A. HOL clearance and receptor-mediated catabolism of LDL are reduced in hypothyroid rats. Atherosclerosis 1987:66:269-275
32. Davidson NO, Powell LM, Wallis SC, Scott J. Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B messenger RNA. J Biol Chem 1988:263:13482-13485
33. Jokinen EV, Landschulz KT, Wyne KL, Ho YK, Frykman PK, Hobbs HH. Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. J Biol Chem 1994:269:2641126418
34. Muls E, Rosseneu M, Lamberigts G, De Moor P. Changes in thé distribution and composition of high-density lipoproteins in primary hypothyroidism. Metabolism 1985:34:345-353
35. O'Brien T, Katz K, Hodge D, Nguyen TT, Kottke BA, Hay ID. The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, All and E. Clin Endocrinol 1997:46:1720
36. Vernon SM, Sarembock IJ, Ayers CR, Powers ER, Gimple LW. Lipoprotein(a) assayed from frozen serum degrades with time in storage [abstract], J Am Coll Card/o/ 1995;25(Special lssue):76A
37. Utermann G. The mysteries of lipoprotein(a). Science 1989:246:904-910
38. Martinez Triguero ML, Garcia Vega L, Mora Herranz A, Andreu Miquel L, Molina Andreu E. Lipoprotema(a). Rev Soc Esp Quim Clin 1993:12:414-421
39. Chait A, Bierman EL, Albers JJ. Regulatory role of triiodothyronine in the degradation of low density lipoprotein by cultured human skin fibroblasts. J Clin Endocrinol Metab 1979:48:887-889
40. Hofmann SL, Eaton DL, Brown MS, McConathy WJ, Goldstein JL, Hammer RE. Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. J Clin Invest 1990:85:1542-1547